This report provides a comprehensive analysis of AstraZeneca's strategic management and sustainability practices. It begins with an introduction to strategic management and its importance for achieving competitive advantage, then focuses on AstraZeneca as a case study. The main body of the report analyzes AstraZeneca's key business strategies, including its focus on innovative science and life-changing medicines, and examines whether these strategies should be pursued or changed, especially in light of the COVID-19 pandemic. It also assesses AstraZeneca's resources and capabilities, such as physical, human, financial, intellectual, and social capital, and evaluates how effectively the company utilizes these resources to support its business strategies. Furthermore, the report examines the implementation of environmental sustainability initiatives by AstraZeneca and how these efforts contribute to its competitive position within the pharmaceutical industry. The analysis considers various aspects of sustainability, including waste reduction and lifecycle analysis. The report concludes with a summary of the findings and recommendations for future strategic directions.
![[object Object]](/_next/static/media/star-bottom.7253800d.svg)
